194 related articles for article (PubMed ID: 28332194)
1. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study.
Lim A; Shayan R; Varigos G
Australas J Dermatol; 2018 Aug; 59(3):182-187. PubMed ID: 28332194
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.
Wyatt C; Lucas RM; Hurst C; Kimlin MG
PLoS One; 2015; 10(5):e0126394. PubMed ID: 25970336
[TBL] [Abstract][Full Text] [Related]
3. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
4. Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.
Moreno-Arrones OM; Zegeer J; Gerbo M; Manrique-Silva E; Requena C; Traves V; Nagore E
Melanoma Res; 2019 Dec; 29(6):664-667. PubMed ID: 31469708
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma.
Timerman D; McEnery-Stonelake M; Joyce CJ; Nambudiri VE; Hodi FS; Claus EB; Ibrahim N; Lin JY
Oncotarget; 2017 Jan; 8(4):6873-6882. PubMed ID: 28036288
[TBL] [Abstract][Full Text] [Related]
6. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.
Saiag P; Aegerter P; Vitoux D; Lebbé C; Wolkenstein P; Dupin N; Descamps V; Aractingi S; Funck-Brentano E; Autier P; Dragomir M; Boniol M
J Natl Cancer Inst; 2015 Dec; 107(12):djv264. PubMed ID: 26376687
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
Newton-Bishop JA; Beswick S; Randerson-Moor J; Chang YM; Affleck P; Elliott F; Chan M; Leake S; Karpavicius B; Haynes S; Kukalizch K; Whitaker L; Jackson S; Gerry E; Nolan C; Bertram C; Marsden J; Elder DE; Barrett JH; Bishop DT
J Clin Oncol; 2009 Nov; 27(32):5439-44. PubMed ID: 19770375
[TBL] [Abstract][Full Text] [Related]
9. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913
[TBL] [Abstract][Full Text] [Related]
10. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma of the foot. A clinicopathological study of 125 primary cutaneous malignant melanomas.
Søndergaard K; Olsen G
Acta Pathol Microbiol Scand A; 1980 Sep; 88(5):275-83. PubMed ID: 7468216
[TBL] [Abstract][Full Text] [Related]
12. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of ulceration of cutaneous melanoma.
Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
[TBL] [Abstract][Full Text] [Related]
14. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in melanoma prognostic factors.
Farahi JM; Fazzari M; Braunberger T; Caravaglio JV; Kretowicz A; Wells K; Dellavalle RP; Norris D; Alkousakis T
Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29905998
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients.
Kuno Y; Ishihara K; Yamazaki N; Mukai K
Jpn J Clin Oncol; 1996 Jun; 26(3):144-51. PubMed ID: 8656554
[TBL] [Abstract][Full Text] [Related]
17. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
18. Associations of Statins and Diabetes with Diagnosis of Ulcerated Cutaneous Melanoma.
von Schuckmann LA; Smith D; Hughes MCB; Malt M; van der Pols JC; Khosrotehrani K; Smithers BM; Green AC
J Invest Dermatol; 2017 Dec; 137(12):2599-2605. PubMed ID: 28842323
[TBL] [Abstract][Full Text] [Related]
19. Ulceration and prognosis in cutaneous malignant melanoma.
McGovern VJ; Shaw HM; Milton GW; McCarthy WH
Histopathology; 1982 Jul; 6(4):399-407. PubMed ID: 7118080
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.
Pizzichetta MA; Massi D; Mandalà M; Queirolo P; Stanganelli I; De Giorgi V; Ghigliotti G; Cavicchini S; Quaglino P; Corradin MT; Rubegni P; Alaibac M; Astorino S; Ayala F; Magi S; Mazzoni L; Manganoni MA; Talamini R; Serraino D; Palmieri G;
J Transl Med; 2017 Nov; 15(1):227. PubMed ID: 29115977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
